Clinical Trial Update: Very Early PCSK9 Inhibition for Acute Myocardial Infarction [NA]

View source ↗

Summary

A clinical trial update indicates a very early PCSK9 inhibition strategy for patients with acute myocardial infarction is currently recruiting. The specific PCS…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Acute Myocardial Infarction (AMI) | NA | Status: RECRUITING